2005
DOI: 10.1016/j.ejphar.2005.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 18 publications
0
11
0
Order By: Relevance
“…Unpredicted however, was the small but statistically significant effect of the preceding chronic FLX treatment on DA release after the acute challenge in both age groups, just as was seen with 5-HT. Previous studies have shown that FLX can indeed acutely affect DA and NA release in the prefrontal cortex, presumably via the 5-HT2c receptor and/or post-synaptic 5-HT1A receptor [30], [40], but other studies have reported no effects on DA and NA concentrations after an acute challenge [41] or directly after chronic administration [42], [43]. Although this effect of previous FLX treatment on the DA response to an acute 5-HT challenge is thus less easily explained, it is clear that almost all 5-HT receptors are capable of modulating DA release [44] and it is therefore not surprising that, considering the effects seen in the 5-HT system, also the DA system is similarly affected.…”
Section: Discussionmentioning
confidence: 98%
“…Unpredicted however, was the small but statistically significant effect of the preceding chronic FLX treatment on DA release after the acute challenge in both age groups, just as was seen with 5-HT. Previous studies have shown that FLX can indeed acutely affect DA and NA release in the prefrontal cortex, presumably via the 5-HT2c receptor and/or post-synaptic 5-HT1A receptor [30], [40], but other studies have reported no effects on DA and NA concentrations after an acute challenge [41] or directly after chronic administration [42], [43]. Although this effect of previous FLX treatment on the DA response to an acute 5-HT challenge is thus less easily explained, it is clear that almost all 5-HT receptors are capable of modulating DA release [44] and it is therefore not surprising that, considering the effects seen in the 5-HT system, also the DA system is similarly affected.…”
Section: Discussionmentioning
confidence: 98%
“…: transversal probe AP 4.5, VD 2.7; Amargos‐Bosch et al . : AP 3.2, L −0.8, DV −6.0; Dazzi et al . : AP 3.2, ML 0.8, VD −5.3.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, NMDA receptor antagonists or genetic deletion of the NMDA receptors raises 5-HT release in the mPFC (Amargos-Bosch et al 2005;Ceglia et al 2004;Miyamoto et al 2001), whereas activation of 5-HT 2A receptors raises cortical GLU release (Scruggs et al 2003), enhances GLU-dependent excitatory postsynaptic currents in cortical slices (Aghajanian and Marek 1999) and c-fos expression (Scruggs et al 2000) in the mPFC. The 5-HT 1A receptors mediate the hyperpolarizing action of 5-HT on glutamatergic prefrontal neurons (Aghajanian and Marek 1997;Amargos-Bosch et al 2004;Zhou and Hablitz 1999).…”
Section: Introductionmentioning
confidence: 99%